Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 22.09.2026 г. · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooperman Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
и още 4

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 22.09.2026 г. · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooper Hospital University Medical Center, Camden
Cooperman Barnabas Medical Center, Livingston
и още 7

Набиране на участнициФаза 2

Възраст от 18 до 59 · Всички полове · Обновено на 22.09.2026 г. · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
и още 4

Набиране на участнициФаза 3

6 Months – 21 Years · Всички полове · Обновено на 17.09.2026 г. · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

John Theurer Cancer Center at Hackensack UMC, Hackensack

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 16.09.2026 г. · NCT06824168

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Atlantic Health, Morristown

Набиране на участнициФаза 1/2

Възраст 12 и повече · Всички полове · Обновено на 3.09.2026 г. · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
и още 3

Набиране на участнициФаза 1/2

До 22 години · Всички полове · Обновено на 25.08.2026 г. · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Hackensack University Medical Center, HMH, Hackensack
Morristown Medical Center, Morristown

Набиране на участнициФаза 3

29 Days – 21 Years · Всички полове · Обновено на 24.08.2026 г. · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Rutgers Biomedical and Health Sciences, New Brunswick

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 20.08.2026 г. · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 20.08.2026 г. · NCT06001788

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

MDA at Cooper University Health Care, Camden

Набиране на участнициРанна фаза 1

Възраст 18 и повече · Всички полове · Обновено на 18.08.2026 г. · NCT07771803

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Atlantic Health, Morristown

Набиране на участнициФаза 2/3

Възраст от 18 до 80 · Всички полове · Обновено на 5.08.2026 г. · NCT06788756

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набиране на участнициФаза 2

Възраст 60 и повече · Всички полове · Обновено на 17.07.2026 г. · NCT07392242

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 7.07.2026 г. · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hackensack University Medical Center, Hackensack
Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick

Набиране на участнициНаблюдателно проучване

Всички възрасти · Всички полове · Обновено на 6.07.2026 г. · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 22.06.2026 г. · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набиране на участнициФаза 1

Възраст 1 и повече · Всички полове · Обновено на 22.06.2026 г. · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Набиране на участнициФаза 1/2

Възраст 12 и повече · Всички полове · Обновено на 22.06.2026 г. · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набиране на участнициФаза 1

Възраст от 18 до 70 · Всички полове · Обновено на 17.06.2026 г. · NCT07011004

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

John Theurer Cancer Center / Hackensack University, Hackensack

Набиране на участнициФаза 2/3

Възраст 18 и повече · Всички полове · Обновено на 30.04.2026 г. · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Atlantic Health, Morristown
Rutgers Cancer Institute of New Jersey, New Brunswick

Набиране на участнициФаза 1/2

Възраст 12 и повече · Всички полове · Обновено на 24.03.2026 г. · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 23.03.2026 г. · NCT04990102

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute, New Brunswick

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 13.03.2026 г. · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 10.03.2026 г. · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 24.02.2026 г. · NCT06773208

От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.